.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
MR-guided focused ultrasound offers an incision-free approach to creating a therapeutic lesion in a deep brain target. In this randomized, sham-controlled trial, patients with markedly asymmetric Parkinson disease and medication-incomplete motor control underwent unilateral focused ultrasound subthalamotomy or a sham procedure. At four months, the active-treatment group showed a substantially greater improvement in the motor score of the more affected side than the control group. The study demonstrated proof of efficacy for lesioning the subthalamic nucleus without open cranial surgery. However, adverse effects—including speech disturbance, gait disturbance, weakness and dyskinesia—were observed, and some persisted. The treatment was studied in a carefully selected population rather than in all patients with Parkinson disease. For HCPs, the clinical message is balanced: focused ultrasound is a promising technology for selected patients with asymmetric, medication-refractory motor symptoms, but it does not eliminate the risks of creating a permanent brain lesion. Patient selection, counselling and specialist movement-disorder assessment remain essential. The trial fits the IANCON emphasis on emerging neuromodulation technologies and on matching advanced interventions to the individual clinical phenotype.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
MR-guided focused ultrasound offers an incision-free approach to creating a therapeutic lesion in a deep brain target. In this randomized, sham-controlled trial, patients with markedly asymmetric Parkinson disease and medication-incomplete motor control underwent unilateral focused ultrasound subthalamotomy or a sham procedure. At four months, the active-treatment group showed a substantially greater improvement in the motor score of the more affected side than the control group. The study demonstrated proof of efficacy for lesioning the subthalamic nucleus without open cranial surgery. However, adverse effects—including speech disturbance, gait disturbance, weakness and dyskinesia—were observed, and some persisted. The treatment was studied in a carefully selected population rather than in all patients with Parkinson disease. For HCPs, the clinical message is balanced: focused ultrasound is a promising technology for selected patients with asymmetric, medication-refractory motor symptoms, but it does not eliminate the risks of creating a permanent brain lesion. Patient selection, counselling and specialist movement-disorder assessment remain essential. The trial fits the IANCON emphasis on emerging neuromodulation technologies and on matching advanced interventions to the individual clinical phenotype.
last month
Preclinical findings demonstrate that ginsenoside Ra1 preserves vascular integrity and attenuates multi-organ injury during sepsis by targeting non-muscle myosin heavy chain IIA (NMMHC IIA) and dampening TLR4/NF-κB/NLRP3 inflammatory signaling.
2 days back
An all-printed immunosensing microchip detects urinary sFlt-1 in just 10 minutes with 3.61 pg/mL sensitivity. By leveraging photonic bandgap engineering, this low-cost, cleanroom-free platform provides non-invasive preeclampsia screening, offering substantial benefits for point-of-care obstetric triage.
3 days back
Wearable ultrasound patches are transforming healthcare by shifting medicine from episodic evaluations to continuous monitoring. Discover how flexible acoustic transducers advance cardiovascular tracking, musculoskeletal imaging, neuromodulation, and on-demand closed-loop theranostics.
3 days back
A breakthrough study leverages natural language processing to accurately identify incident medication-related osteonecrosis of the jaw and track antiresorptive drug holidays from clinical narratives in electronic health records, advancing osteoporosis pharmacovigilance and dental safety.
Last week
Recent research defines ferro-aging as a conserved iron-lipid axis driving organ decline across primates. Age-related iron dyshomeostasis stimulates ACSL4-mediated lipid peroxidation, promoting cellular senescence. Notably, vitamin C directly inhibits ACSL4, suppressing phospholipid oxidation and multi-organ decay.
Last week
